Drug intelligence / Profile preview

polyethylene glycol 400 + propylene glycol (Kilitch Drugs (India) Ltd)

Development stage: Phase 4
Lead developer: Eyekare Kilitch
Modality: Small Molecules
Administration: Ophthalmic

Overview

Haloeye PG is an ophthalmic lubricant solution developed and marketed by Eyekare Kilitch. It is a fixed-dose combination of polyethylene glycol 400 (0.4% w/v) and propylene glycol (0.3% w/v). The eye drops are indicated for the temporary relief of burning, irritation, and discomfort caused by dry eyes. By acting as demulcents, the active ingredients mimic natural tears to lubricate and protect the ocular surface, helping to restore moisture and reduce redness and swelling.

Brand names: Haloeye Hydra PFHaloeye PG
Other names: polyethylene glycol 400 + propylene glycol

Beyond the preview

Go deeper on polyethylene glycol 400 + propylene glycol (Kilitch Drugs (India) Ltd).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on polyethylene glycol 400 + propylene glycol (Kilitch Drugs (India) Ltd).